Alimera Sciences' ILUVIENĀ® Receives Marketing Authorization in Portugal for the Treatment of Chronic Diabetic Macular Edema

Alimera announced it has received authorization to market ILUVIENT for the treatment of vision impairment associated with chroni... [more]

View complete Press Release article